QWB · Class II · 21 CFR 866.3984

FDA Product Code QWB: Over-the-counter Molecular Test To Detect Sars-cov-2 From Clinical Specimens

An Over-the-counter Molecular Test To Detect Sars-cov-2 Is An In Vitro Diagnostic Device For The Detection Of Sars-cov-2 In Clinical Specimens To Aid In The Diagnosis Of Sars-cov-2 Infection. The Device Is Intended To Be Used By Lay Users And Without Health Care Provider (hcp) Intervention In Home Settings Or Similar Environments.

Leading manufacturers include Cue Health, Inc. and Aptitude Medical Systems, Inc..

3
Total
2
Cleared
265d
Avg days
2023
Since
Declining activity - 1 submissions in the last 2 years vs 2 in the prior period
Review times increasing: avg 305d recently vs 245d historically

FDA 510(k) Cleared Over-the-counter Molecular Test To Detect Sars-cov-2 From Clinical Specimens Devices (Product Code QWB)

3 devices
1–3 of 3

About Product Code QWB - Regulatory Context

510(k) Submission Activity

3 total 510(k) submissions under product code QWB since 2023, with 2 receiving FDA clearance (average review time: 265 days).

Submission volume has declined in recent years - 1 submissions in the last 24 months compared to 2 in the prior period.

FDA 510(k) Review Time - QWB Product Code

Recent submissions under QWB have taken an average of 305 days to reach a decision - up from 245 days historically. Manufacturers should account for longer review timelines in current project planning.

QWB devices are reviewed by the Microbiology panel. Browse all Microbiology devices →